The Daily cover image

Why One Drug Company Held Back a Better Drug

The Daily

Gilead's Decision to Halt Development of New Drug to Maximize Profits

2min Snip

0
00:00
Play full episode
Gilead halted the development of a potentially better drug in order to maximize profits by keeping prices high. The documents suggest that the company didn't want to waste the precious patent and the newer version of the drug remained on the shelf for years while the older version continued to be sold.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode